Natural killer T cells in mucosal homeostasis

Annals of the New York Academy of Sciences

Volumn 1029, Issue , 2004, Pages 154-168

  Kaser, Arthur ^a   Nieuwenhuis, Edward E S ^a,b   Strober, Warren ^c   Mayer, Lloyd ^d   Fuss, Ivan ^c   Colgan, Sean ^a   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presenting cells; CD1; CD1d; Epithelial cells; Inflammatory bowel disease; Mucosal homeostasis; Natural killer T (NKT) cells

Indexed keywords

CD1 ANTIGEN; CD1D ANTIGEN;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; CLONAL ANERGY; CONFERENCE PAPER; ENTERITIS; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE; MUCOSA; MUCOSA ASSOCIATED LYMPHOID TISSUE; MUCOSAL HOMEOSTASIS; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE SUBPOPULATION;

EID: 14544275824     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1309.032     Document Type: Conference Paper

References (62)

1. CALABI, F. & C. MILSTEIN. 1986. A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature 323: 540-543.
2. MARTIN, L.H., F. CALABI & C. MILSTEIN. 1986. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc. Natl. Acad. Sci. USA 83: 9154-9158.
3. DASCHER, C.C. & M.B. BRENNER. 2003. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol. 24: 412-418.
4. BLUMBERG, R.S., D. GERDES, A. CHOTT, et al. 1995. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol. Rev. 147: 5-29.
5. ZENG, Z., A.R. CASTANO, B.W. SEGELKE, et al. 1997. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277: 339-345.
6. ZAJONC, D.M., M.A. ELSLIGER, L. TEYTON & I.A. WILSON. 2003. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat. Immunol. 4: 808-815.
7. GUMPERZ, J.E. & M.B. BRENNER. 2001. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13: 471-478.
8. KAWANO, T., J. CUI, Y. KOEZUKA, et al. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
9. GUMPERZ, J.E., C. ROY, A. MAKOWSKA, et al. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
10. KRONENBERG, M. & L. GAPIN. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
11. LANTZ, O. & A. BENDELAC. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4- 8- T cells in mice and humans. J. Exp. Med. 180: 1097-1106.
12. BEHAR, S.M., T.A. PODREBARAC, C.J. ROY, et al. 1999. Diverse TCRs recognize murine CD1. J. Immunol. 162: 161-167.
13. RIESE, R.J., G.P. SHI, J. VILLADANGOS, et al. 2001. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity 15: 909-919.
14. PARK, S.H., A. WEISS, K. BENLAGHA, et al. 2001. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J. Exp. Med. 193: 893-904.
15. EBERL, G., R. LEES, S.T. SMILEY, et al. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162: 6410-6419.
16. SLIFKA, M.K., R.R. PAGARIGAN & J.L. WHITTON. 2000. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J. Immunol. 164: 2009-2015.
17. WILSON, S.B. & T.L. DELOVITCH. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3: 211-222.
18. GUMPERZ, J.E., S. MIYAKE, T. YAMAMURA & M.B. BRENNER. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
19. KADOWAKI, N., S. ANTONENKO, S. HO, et al. 2001. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193: 1221-1226.
20. MATSUDA, J.L., L. GAPIN, J.L. BARON, et al. 2003. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100: 8395-8400.
21. LEE, P.T., K. BENLAGHA, L. TEYTON & A. BENDELAC. 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195: 637-641.
22. KANEKO, Y., M. HARADA, T. KAWANO, et al. 2000. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114.
23. YANG, O.O., F.K. RACKE, P.T. NGUYEN, et al. 2000. CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: a feedback mechanism for immune regulation. J. Immunol. 165: 3756-3762.
24. STROMINGER, J.L., M.C. BYRNE & S.B. WILSON. 2003. Regulation of dendritic cell subsets by NKT cells. C. R. Biol. 326: 1045-1048.
25. KAWAKAMI, K., N. YAMAMOTO, Y. KINJO, et al. 2003. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33: 3322-3330.
26. SMILEY, S.T., M.H. KAPLAN & M.J. GRUSBY. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275: 977-979.
27. CHEN, Y.H., N.M. CHIU, M. MANDAL, et al. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467.
28. MENDIRATTA, S.K., W.D. MARTIN, S. HONG, et al. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
29. BLUMBERG, R.S., L.J. SAUBERMANN & W. STROBER. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11: 648-656.
30. STROBER, W., I.J. FUSS & R.S. BLUMBERG. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
31. HELLER, F., I.J. FUSS, E.E. NIEUWENHUIS, et al. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 17: 629-638.
32. AKBARI, O., P. STOCK, E. MEYER, et al. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
33. PARK, S.H., K. BENLAGHA, D. LEE, et al. 2000. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur. J. Immunol. 30: 620-625.
34. BLUMBERG, R.S. & W. STROBER. 2001. Prospects for research in inflammatory bowel disease. JAMA 285: 643-647.
35. SAUBERMANN, L.J., P. BECK, Y.P. DE JONG, et al. 2000. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119: 119-128.
36. UENO, Y., M. SUMII, S. TANAKA, et al. 2003. OCH, a newly synthetic glycolipid, enhances protective immunity against mouse DSS-induced colitis in the presence of Valpha14 natural killer T cells [abstract]. Gastroenterology 124: A-36.
37. BOIRIVANT, M., I.J. FUSS, A. CHU & W. STROBER. 1998. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188: 1929-1939.
38. NEURATH, M.F., S. FINOTTO & L.H. GLIMCHER. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8: 567-573.
39. NIEUWENHUIS, E.E., M.F. NEURATH, N. CORAZZA, et al. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA 99: 16951-16956.
40. TRINCHIERI, G., S. PFLANZ & R.A. KASTELEIN. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 19: 641-644.
41. PFLANZ, S., J.C. TIMANS, J. CHEUNG, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790.
42. PFLANZ, S., L. HIBBERT, J. MATTSON, et al. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172: 2225-2231.
43. OMATA, F., M. BIRKENBACH, S. MATSUZAKI, et al. 2001. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease. Inflamm. Bowel. Dis. 7: 215-220.
44. CHRIST, A.D., A.C. STEVENS, H. KOEPPEN, et al. 1998. An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Gastroenterology 115: 307-313.
45. PODOLSKY, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
46. NIEUWENHUIS, E.E., T. MATSUMOTO, M. EXLEY, et al. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593.
47. CHEUNG, D.O., K. HALSEY & D.P. SPEERT. 2000. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun. 68: 4585-4592.
48. BALK, S.P., S. BURKE, J.E. POLISCHUK, et al. 1994. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265: 259-262.
49. BLUMBERG, R.S., C. TERHORST, P. BLEICHER, et al. 1991. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147: 2518-2524.
50. BLEICHER, P.A., S.P. BALK, S.J. HAGEN, et al. 1990. Expression of murine CD1 on gastrointestinal epithelium. Science 250: 679-682.
51. CANCHIS, P.W., A.K. BHAN, S.B. LANDAU, et al. 1993. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology 80: 561-565.
52. BALK, S.P., P.A. BLEICHER & C. TERHORST. 1989. Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule. Proc. Natl. Acad. Sci. USA 86: 252-256.
53. KIM, H.S., J. GARCIA, M. EXLEY, et al. 1999. Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J. Biol. Chem. 274: 9289-9295.
54. SOMNAY-WADGAONKAR, K., A. NUSRAT, H.S. KIM, et al. 1999. Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int. Immunol. 11: 383-392.
55. KIM, H.S., S.P. COLGAN, R. PITMAN, et al. 2000. Human CD1d associates with prolyl-4-hydroxylase during its biosynthesis. Mol. Immunol. 37: 861-868.
56. VAN DE, W.Y., N. CORAZZA, M. ALLEZ, et al. 2003. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124: 1420-1431.
57. PRIGOZY, T.I., O. NAIDENKO, P. QASBA, et al. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664-667.
58. COLGAN, S.P., R.M. HERSHBERG, G.T. FURUTA & R.S. BLUMBERG. 1999. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 96: 13938-13943.
59. COLGAN, S.P., V.M. MORALES, J.L. MADARA, et al. 1996. IFN-gamma modulates CD1d surface expression on intestinal epithelia. Am. J. Physiol. 271: C276-C283.
60. CAMPBELL, N.A., H.S. KIM, R.S. BLUMBERG & L. MAYER. 1999. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells. J. Biol. Chem. 274: 26259-26265.
61. YIO, X.Y. & L. MAYER. 1997. Characterization of a 180-kDa intestinal epithelial cell membrane glycoprotein, gp180. A candidate molecule mediating t cell-epithelial cell interactions. J. Biol. Chem. 272: 12786-12792.
62. COLGAN, S.P., R.S. PITMAN, T. NAGAISHI, et al. 2003. Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells. J. Clin. Invest 112: 745-754.